Reviva Pharmaceuticals Says it Plans to Submit Investigational New Drug Application for Psoriasis Drug Brilaroxazine in 2024

Reviva Pharmaceuticals Says it Plans to Submit Investigational New Drug Application for Psoriasis Drug Brilaroxazine in 2024

MT Newswires · 05/11/2023 04:46

Please log in to view news